IL59177A - Spirofuro-(and pyrano)-quinolylhydantoins and pharmaceutical compositions containing them - Google Patents
Spirofuro-(and pyrano)-quinolylhydantoins and pharmaceutical compositions containing themInfo
- Publication number
- IL59177A IL59177A IL59177A IL5917780A IL59177A IL 59177 A IL59177 A IL 59177A IL 59177 A IL59177 A IL 59177A IL 5917780 A IL5917780 A IL 5917780A IL 59177 A IL59177 A IL 59177A
- Authority
- IL
- Israel
- Prior art keywords
- spirofuro
- quinolylhydantoins
- pyrano
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/005,278 US4176185A (en) | 1979-01-22 | 1979-01-22 | Spiro-quinolylhydantoins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL59177A0 IL59177A0 (en) | 1980-05-30 |
| IL59177A true IL59177A (en) | 1982-11-30 |
Family
ID=21715098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL59177A IL59177A (en) | 1979-01-22 | 1980-01-21 | Spirofuro-(and pyrano)-quinolylhydantoins and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4176185A (de) |
| EP (1) | EP0014079B1 (de) |
| JP (1) | JPS5840959B2 (de) |
| KR (1) | KR830001940A (de) |
| AR (1) | AR222685A1 (de) |
| AT (1) | AT365588B (de) |
| AU (1) | AU514271B2 (de) |
| CA (1) | CA1140928A (de) |
| DE (1) | DE3060079D1 (de) |
| DK (1) | DK156399C (de) |
| EG (1) | EG15085A (de) |
| ES (1) | ES487923A0 (de) |
| FI (1) | FI69308C (de) |
| GR (1) | GR72408B (de) |
| IE (1) | IE49365B1 (de) |
| IL (1) | IL59177A (de) |
| NO (1) | NO152172C (de) |
| NZ (1) | NZ192650A (de) |
| PH (1) | PH15472A (de) |
| PT (1) | PT70716A (de) |
| YU (1) | YU41692B (de) |
| ZA (1) | ZA80344B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
| US4490381A (en) * | 1979-11-13 | 1984-12-25 | Imperial Chemical Industries Plc | 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| DE3261684D1 (en) * | 1981-05-12 | 1985-02-07 | Ici Plc | Pyrrole derivatives |
| WO1989001775A1 (en) * | 1987-09-04 | 1989-03-09 | Pfizer Inc. | Azolidinedione derivatives |
| US5068333A (en) * | 1990-03-07 | 1991-11-26 | Pfizer Inc. | 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| US3876659A (en) * | 1970-09-18 | 1975-04-08 | Sandoz Ag | Spiro tricyclic isoindolines |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
-
1979
- 1979-01-22 US US06/005,278 patent/US4176185A/en not_active Expired - Lifetime
- 1979-12-28 NO NO794318A patent/NO152172C/no unknown
-
1980
- 1980-01-12 EG EG36/80A patent/EG15085A/xx active
- 1980-01-18 NZ NZ192650A patent/NZ192650A/en unknown
- 1980-01-18 EP EP80300170A patent/EP0014079B1/de not_active Expired
- 1980-01-18 CA CA000343984A patent/CA1140928A/en not_active Expired
- 1980-01-18 DE DE8080300170T patent/DE3060079D1/de not_active Expired
- 1980-01-18 AR AR279683A patent/AR222685A1/es active
- 1980-01-18 YU YU131/80A patent/YU41692B/xx unknown
- 1980-01-18 AT AT0026780A patent/AT365588B/de not_active IP Right Cessation
- 1980-01-21 IE IE109/80A patent/IE49365B1/en unknown
- 1980-01-21 IL IL59177A patent/IL59177A/xx unknown
- 1980-01-21 DK DK024280A patent/DK156399C/da not_active IP Right Cessation
- 1980-01-21 FI FI800163A patent/FI69308C/fi not_active IP Right Cessation
- 1980-01-21 KR KR1019800000213A patent/KR830001940A/ko not_active Ceased
- 1980-01-21 JP JP55005610A patent/JPS5840959B2/ja not_active Expired
- 1980-01-21 PH PH23529A patent/PH15472A/en unknown
- 1980-01-21 AU AU54766/80A patent/AU514271B2/en not_active Ceased
- 1980-01-21 ZA ZA00800344A patent/ZA80344B/xx unknown
- 1980-01-21 PT PT70716A patent/PT70716A/pt not_active IP Right Cessation
- 1980-01-22 ES ES487923A patent/ES487923A0/es active Granted
- 1980-11-21 GR GR60999A patent/GR72408B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE49365B1 (en) | 1985-09-18 |
| DK156399B (da) | 1989-08-14 |
| NO152172C (no) | 1985-08-14 |
| ZA80344B (en) | 1981-02-25 |
| AR222685A1 (es) | 1981-06-15 |
| PH15472A (en) | 1983-01-24 |
| EP0014079B1 (de) | 1981-11-18 |
| AT365588B (de) | 1982-01-25 |
| JPS5840959B2 (ja) | 1983-09-08 |
| DE3060079D1 (en) | 1982-01-21 |
| EG15085A (en) | 1986-12-30 |
| DK24280A (da) | 1980-07-23 |
| FI69308B (fi) | 1985-09-30 |
| KR830001940A (ko) | 1983-05-19 |
| IE800109L (en) | 1980-07-22 |
| PT70716A (en) | 1980-02-01 |
| FI800163A7 (fi) | 1980-07-23 |
| FI69308C (fi) | 1986-01-10 |
| CA1140928A (en) | 1983-02-08 |
| YU13180A (en) | 1983-01-21 |
| US4176185A (en) | 1979-11-27 |
| NO794318L (no) | 1980-07-23 |
| AU5476680A (en) | 1980-07-31 |
| NZ192650A (en) | 1984-04-27 |
| AU514271B2 (en) | 1981-01-29 |
| ATA26780A (de) | 1981-06-15 |
| DK156399C (da) | 1990-01-08 |
| ES8103090A1 (es) | 1981-02-16 |
| ES487923A0 (es) | 1981-02-16 |
| JPS55108873A (en) | 1980-08-21 |
| IL59177A0 (en) | 1980-05-30 |
| GR72408B (de) | 1983-11-02 |
| NO152172B (no) | 1985-05-06 |
| EP0014079A1 (de) | 1980-08-06 |
| YU41692B (en) | 1987-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL51660A0 (en) | Hentriakontapeptides their preparation and pharmaceutical compositions containing them | |
| IL59288A (en) | 1-aryl-2-acylamido-3-fluoro-1-propanols,their preparation and pharmaceutical compositions containing them | |
| IL59150A (en) | N-benzyl-imidazoles,their preparation and pharmaceutical compositions containing them | |
| GB2051788B (en) | 3 - thiovinyl - cephalosporins their preparation and compositions containing them | |
| MY8700186A (en) | 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them | |
| DE3168067D1 (en) | 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them | |
| IL60678A0 (en) | 3-amino-syndone-imines, their preparation and pharmaceutical compositions containing them | |
| IL60918A (en) | 6-pyridazinones,their preparation and pharmaceutical compositions containing them | |
| PH16443A (en) | Substituted tetraazetricyclic compounds and their pharmaceutical compositions | |
| IL64054A (en) | Imidazolylpyridines and pharmaceutical compositions containing them | |
| IL61117A (en) | 2beta-acetoxymethyl-penam compounds and pharmaceutical compositions containing them | |
| IL60307A0 (en) | Alkoxybenzylpyridopyrimidines,their preparation and pharmaceutical compositions containing them | |
| IL60376A (en) | 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them | |
| IL52137A0 (en) | Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them | |
| GB2048671B (en) | Pharmaceutical composition containing dihydroegotoxine | |
| IL59177A0 (en) | Spiro-quinolylhydantoins and pharmaceutical compositions containing them | |
| PH16220A (en) | Pyrro-lidine derivatives and pharmaceutical compositions thereof | |
| IL57667A (en) | 2-azaergolines and 2-aza-8-ergolines,their preparation and pharmaceutical compositions containing them | |
| DE3064666D1 (en) | Pharmaceutical compositions containing paracetamol | |
| JPS5629590A (en) | 100halooeehomoeburnane derivatives* their manufacture and medicinal composition containing them | |
| IL51468A0 (en) | Novel d-homosteroids their preparation and pharmaceutical compositions containing them | |
| IL60695A0 (en) | Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them | |
| IL60332A0 (en) | Pyridylaminotriazole derivatives and pharmaceutical compositions containing them | |
| IL61038A (en) | 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them | |
| IL61626A0 (en) | 6-pyridinyl-pyridazine derivatives and pharmalceutical compositions containing them |